INTERNATIONAL
WHO says China's Sinopharm, Sinovac vaccines meet efficacy standards
The vaccine makers shared their data with the WHO's Strategic Advisory Group of Experts on Immunisation last week. REUTERS pic
GENEVA: Clinical trial data on Chinese COVID-19 vaccines Sinopharm and Sinovac meets efficacy standards set by the World Health Organisation, the UN agency's lead expert on immunisation said Wednesday.
The vaccine makers shared their data with the WHO's Strategic Advisory Group of Experts on Immunisation last week, Alejandro Cravioto told reporters in Geneva, according to Sputnik.
"The information that the companies shared publicly at the meeting last week clearly indicates that they have levels of efficacy that would be compatible with the requirements," he said.
Cravioto added that both vaccines lacked data on trials in elderly patients and people with comorbidities. He stressed that further safety and efficacy studies were needed to assess the impact of the shots on sub-populations.
-- BERNAMA
The vaccine makers shared their data with the WHO's Strategic Advisory Group of Experts on Immunisation last week, Alejandro Cravioto told reporters in Geneva, according to Sputnik.
"The information that the companies shared publicly at the meeting last week clearly indicates that they have levels of efficacy that would be compatible with the requirements," he said.
Cravioto added that both vaccines lacked data on trials in elderly patients and people with comorbidities. He stressed that further safety and efficacy studies were needed to assess the impact of the shots on sub-populations.
-- BERNAMA